Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 10/20 | 0.44 |
| ▸ | NPY1R | P25929 | 6/20 | 0.44 |
| ▸ | NPY2R | P49146 | 6/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.44 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.43 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.41 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.41 |
| ▸ | GHSR | Q92847 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29884151 | 0.94 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RGHSR | |
| SCHEMBL30592734 | 0.94 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RGHSR | |
| SCHEMBL30838805 | 0.89 | NPY4R (0.53) | NPY4RNPY1RNPY2RNPY5RUTS2R | |
| SCHEMBL30540722 | 0.87 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5RC5AR1 | |
| SCHEMBL29462006 | 0.86 | GHSR (0.49) | GHSR | |
| SCHEMBL29540760 | 0.86 | GHSR (0.49) | GHSR | |
| SCHEMBL29868927 | 0.85 | NPY4R (0.57) | NPY4RNPY1RNPY2RNPY5RC5AR1 | |
| SCHEMBL23362938 | 0.85 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RUTS2R | |
| SCHEMBL23362939 | 0.85 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RUTS2R | |
| SCHEMBL6824254 | 0.84 | LNPEP (0.47) | NPY4RNPY1RNPY2RNTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240122823-A1 | MULTISOME LIPID VESICLES FOR DELIVERY OF COSMETIC AGENTS | GLO PHARMA, INC. | 2024-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240122823-A1 | MULTISOME LIPID VESICLES FOR DELIVERY OF COSMETIC AGENTS | LIPA, PLIN5, LIPE | NPY4R 4254/4885NPY1R 4109/4885NPY2R 4127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.